Administrative regulatory submission management services in the nature of assisting others in preparing and filing applications for new drugs with governmental regulatory bodies, in particular relating to the submission of NDAS (new drug applications) to the FDA (us food and drug administration) and MAAS (marketing authorisation applications) to the EMA (European medicine agency); information and consultancy relating to the aforesaid services